Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2023; 48(1): 173-178


Spectrum of microbial agents responsible for bloodstream infection and their sensitivity pattern in pediatric patients having chemotherapy induced neutropenia

Ghulam Jelani, Nuzhat Yasmeen, Nighat Haider, Bilal Ali Anjum, Jai Krishin, Maqbool Hussain.




Abstract

Objective: To identify the microbial agents responsible for bloodstream infection and their sensitivity pattern in pediatric patients having chemotherapy induced neutropenia.
Methodology: It was an observational, cross-sectional study carried out from April 2020 to November 2020 at department of pediatric oncology & pathology, Pakistan Institute of Medical Sciences, Islamabad. A total of 223 patients of both gender between 3 to 12 years of age with chemotherapy induced febrile neutropenia were enrolled. The blood samples showing growth of bacterial agents on culture medium were identified and antibiograms of these samples were recorded.
Results: Fifty eight percent patients were culture positive. Most frequent pathogen identified was coagulase negative S. aureus (40%) followed by Pseudomonas (37%) and E. coli. (11%). Sensitivity analysis revealed that 58% of S. aureus were sensitive to chloramphenicol, doxycycline, linezolid and vancomycin and 67% of Pseudomonas spp. showed sensitivity to imipenem, levofloxacin, amikacin and piperacillin+tazobactam. All identified E. coli were sensitive to amikacin, piperacillin+tazobactam, imipenem and cefoperazone. All identified Acinobacter were sensitive to only imipenem.
Conclusion: Frequency of febrile neutropenia is highest in younger age group and gram positive organisms are the commonest found on culture followed by gram negative pathogens and Fungai.

Key words: Febrile neutropenia, ALL, chemotherapy induced neutropenia.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.